Delivery Order SPE2DB22D1106-SPE2DB24FEVG3

Award Date 6/4/24
Potential Completion Date 6/5/24
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,166.58 firm-fixed-price delivery order is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a prescription medication, with a completion date of May 30, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical as...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $3,491.80 firm-fixed price delivery order is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive...
The federal contract award was made to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the provision of Imitrex 6 mg/0.5 ml pen injectors. This is a firm fixed price delivery order with a ceiling value of $1,355.16 and a period of performance through April 12, 2024. The contract does not have a...
The U.S. Government awarded a Firm Fixed Price Delivery Order contract valued at $1,476.05 to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,589,613 IMITREX 6 MG/0.5 ML PEN INJECTs. This contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary agency responsible for providing pharmaceutical products and medical supplies to the Department of Defense (DoD) and other government agencies....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $5,213.98 firm-fixed-price delivery order is for the provision of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $8,495.68 for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and an ultimate completion date of November 27, 2024. The award was made on November 26, 2024, and there was no set-aside designation used. Amerisourcebergen...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen). The contract is for the delivery of a pharmaceutical product, Imitrex 6 mg/0.5 mL pen injections, with a ceiling value of $2,773.68 and a completion date of April 17, 2024. The contract is a Firm Fixed Price Delivery Order, awarded without any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML. The delivery order has a total ceiling value of $2,828.81 and a completion date of November 1, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml pen injectors. The fixed-price delivery order, valued at $12,343.56, has an ultimate completion date of September 20, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, to deliver a wide range of medical...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $1,476.05 firm fixed-price contract is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a specialty medication, to support military treatment facilities and federal healthcare programs. This award is not associated with a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEVG3
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $5,825.24 Firm Fixed Price Delivery Order is for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a prescription medication, with a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. This contract does not have a set-aside designation.

Generated 9/3/24, 12:17 PM